These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 8254189)

  • 1. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.
    Parker KC; Bednarek MA; Coligan JE
    J Immunol; 1994 Jan; 152(1):163-75. PubMed ID: 8254189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.
    Parker KC; Bednarek MA; Hull LK; Utz U; Cunningham B; Zweerink HJ; Biddison WE; Coligan JE
    J Immunol; 1992 Dec; 149(11):3580-7. PubMed ID: 1331239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta 2-microglobulin dissociation rate is an accurate measure of the stability of MHC class I heterotrimers and depends on which peptide is bound.
    Parker KC; DiBrino M; Hull L; Coligan JE
    J Immunol; 1992 Sep; 149(6):1896-904. PubMed ID: 1517560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations.
    Chen Y; Sidney J; Southwood S; Cox AL; Sakaguchi K; Henderson RA; Appella E; Hunt DF; Sette A; Engelhard VH
    J Immunol; 1994 Mar; 152(6):2874-81. PubMed ID: 8144888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site.
    Collins EJ; Garboczi DN; Wiley DC
    Nature; 1994 Oct; 371(6498):626-9. PubMed ID: 7935798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules.
    Sette A; Vitiello A; Farness P; Furze J; Sidney J; Claverie JM; Grey HM; Chesnut R
    J Immunol; 1991 Dec; 147(11):3893-900. PubMed ID: 1658152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution by MHC-restricted peptides of HLA-A2 heavy chain with beta 2-microglobulin, in vitro.
    Silver ML; Parker KC; Wiley DC
    Nature; 1991 Apr; 350(6319):619-22. PubMed ID: 2017257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural prediction of peptides binding to MHC class I molecules.
    Bui HH; Schiewe AJ; von Grafenstein H; Haworth IS
    Proteins; 2006 Apr; 63(1):43-52. PubMed ID: 16447245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design.
    Schiewe AJ; Haworth IS
    J Mol Graph Model; 2007 Oct; 26(3):667-75. PubMed ID: 17493854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC-peptide binding: dimers of cysteine-containing nonapeptides bind with high affinity to HLA-A2.1 class I molecules.
    Di Modugno F; Mammi C; Rosanò L; Rubiu O; Nisticò P; Chersi A
    J Immunother; 1997 Nov; 20(6):431-6. PubMed ID: 9409448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
    Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
    J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in MHC class I self peptide repertoires among HLA-A2 subtypes.
    Sudo T; Kamikawaji N; Kimura A; Date Y; Savoie CJ; Nakashima H; Furuichi E; Kuhara S; Sasazuki T
    J Immunol; 1995 Nov; 155(10):4749-56. PubMed ID: 7594476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes.
    Gavioli R; Zhang QJ; Marastoni M; Guerrini R; Reali E; Tomatis R; Masucci MG; Traniello S
    Biochem Biophys Res Commun; 1995 Jan; 206(1):8-14. PubMed ID: 7818553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranking potential binding peptides to MHC molecules by a computational threading approach.
    Altuvia Y; Schueler O; Margalit H
    J Mol Biol; 1995 Jun; 249(2):244-50. PubMed ID: 7540211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2.
    Guichard G; Connan F; Graff R; Ostankovitch M; Muller S; Guillet JG; Choppin J; Briand JP
    J Med Chem; 1996 May; 39(10):2030-9. PubMed ID: 8642561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative structure-activity relations by the MTD-method for binding of nonapeptides to the HLA-A2.1 molecule.
    Bologa C; Drugărin D; Simon Z
    Roum Arch Microbiol Immunol; 1995; 54(1-2):3-14. PubMed ID: 8993110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
    Takahashi T; Irie RF; Nishinaka Y; Hoon DS
    Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of peptide affinity to HLA DRB1*0401.
    Marshall KW; Wilson KJ; Liang J; Woods A; Zaller D; Rothbard JB
    J Immunol; 1995 Jun; 154(11):5927-33. PubMed ID: 7751636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Bayesian neural network models of MHC class II peptide binding.
    Burden FR; Winkler DA
    J Mol Graph Model; 2005 Jun; 23(6):481-9. PubMed ID: 15878832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of peptide binding to purified antibody-bound H-2Db and H-2Db beta 2m complexes.
    Burshtyn DN; Barber BH
    J Immunol; 1993 Sep; 151(6):3082-93. PubMed ID: 7690793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.